Rigel Expands Oncology Portfolio With VEPPANU Licensing Deal
SOUTH SAN FRANCISCO, Calif., May 12, 2026 Rigel Pharmaceuticals has entered into an exclusive global licensing agreement with Arvinas...
M&A
Advertisement
LEO Pharma Acquires Replay to Boost Gene Therapy
Ballerup, Denmark | April 30, 2026 LEO Pharma has announced a definitive agreement to acquire Replay, significantly expanding its...
Fagron Expands U.S. Compounding Platform With UCP Deal
Nazareth, Belgium / Rotterdam, Netherlands | January 12, 2026 — Fagron has completed the acquisition of University Compounding Pharmacy...
Novo Nordisk Finalizes Akero Deal to Advance MASH Phase 3 Therapy
Bagsværd, Denmark & South San Francisco, CA — December 9, 2025 — Novo Nordisk has officially completed its acquisition...
Natera Strengthens MRD Leadership With Acquisition of Foresight Diagnostics
AUSTIN, Texas — December 5, 2025 — Natera has announced the acquisition of Foresight Diagnostics, a precision oncology company...
Advertisements
Pfizer Challenges Novo Nordisk’s Proposal to Acquire Metsera
New York, October 30, 2025 — Pfizer Inc. (NYSE: PFE) has issued a strong response to what it calls...
Roche Completes Acquisition of 89bio in Strategic Biotech Expansion
Basel, Switzerland – October 30, 2025 — Roche Holding AG (SIX: RO, ROG; OTCQX: RHHBY) has successfully completed its...
PureHealth Completes €800M Acquisition of Hellenic Healthcare Group
ABU DHABI, UAE, Oct. 7, 2025 — PureHealth Holding PJSC announced the completion of its €800 million acquisition of...
Pulse Biosciences Secures FDA IDE Approval to Launch Clinical Trial of nsPFA Cardiac Surgery System for Atrial Fibrillation
Hayward, CA – September 9, 2025 – Pulse Biosciences, a pioneer in bioelectric medicine and nanosecond pulsed field ablation...
Novartis to Acquire Tourmaline Bio, Expanding ASCVD Pipeline
September 9, 2025 – Basel – In a move set to strengthen its cardiovascular disease portfolio, Novartis announced an...
Advertisement
